10-Q: USANA Health Sciences Reports Lower Sales and Earnings in Second Quarter 2024

USANA Health Sciences experienced a decrease in both sales and earnings for the second quarter of 2024, primarily due to a decline in active customers and average customer spend.

Summary

• USANA Health Sciences reported a 10.6% decrease in net sales for the second quarter of 2024, totaling $212.9 million, compared to the same period last year.
• The company's net earnings for the quarter were $10.4 million, a 39.7% decrease from $17.3 million in the prior-year quarter.
• The decline in sales was attributed to a decrease in active customers and a reduction in average customer spending, partially offset by modest price increases.
• Unfavorable currency exchange rates negatively impacted net sales by an estimated $5.3 million.
• The company's gross profit margin decreased to 81.1% from 81.8% in the prior-year quarter, due to unfavorable currency exchange rates and lower sales volume.
• The effective tax rate increased to 43.0% year-to-date, compared to 35.5% in the same period of 2023, impacting net earnings.
• Diluted earnings per share (EPS) decreased by 39.3% to $0.54, compared to $0.89 in the prior-year quarter.
• Active customers decreased by 3.9% year-over-year, reaching approximately 468,000 worldwide.

Sentiment

Score: 3

Explanation: The document indicates a significant downturn in sales and earnings, coupled with a decrease in active customers. The company is facing challenges in multiple regions and is experiencing unfavorable currency impacts. While there are some positive aspects, the overall tone is negative from an investment perspective.

Positives

• Associate incentives decreased 50 basis points to 42.5% of net sales, down from 43.0% in the prior-year quarter.
• Selling, general and administrative expenses decreased $3.8 million in absolute terms.
• The company's cash and cash equivalents increased to $332.4 million as of June 29, 2024, from $330.4 million as of December 30, 2023.
• The company remitted profits through an annual dividend of $75.8 million from its China subsidiary to the United States.

Negatives

• Net sales decreased by 10.6% in the second quarter of 2024.
• Net earnings decreased by 39.7% in the second quarter of 2024.
• The company experienced a decrease in active customers and average customer spend.
• Unfavorable currency exchange rates negatively impacted net sales.
• Gross profit margin decreased to 81.1% from 81.8% in the prior-year quarter.
• The effective tax rate increased to 43.0% year-to-date.
• Diluted EPS decreased by 39.3% to $0.54.
• The company experienced a decline in sales in China, South Korea, and the Philippines.
• The company experienced a decline in sales in the United States and Canada.

Risks

• The company's reliance on the direct selling business model and the activities of its independent associates.
• Extensive regulation of the business model and uncertainties relating to the interpretation and enforcement of applicable laws and regulations.
• The operation and expansion of the business in China, including risks related to operating in China, direct selling in China, and changes in the Chinese economy.
• Effects of changes to the company's compensation plan.
• Product liability claims, litigation, or other liability associated with the products.
• Challenges associated with expansion into new international markets.
• Macroeconomic conditions, including inflationary pressures, slower economic growth, and disruptions to the supply chain.
• Geopolitical tensions or conflicts, including impacts from the conflicts involving Russia and Ukraine, and Israel and Palestine.
• Volatile fluctuation in the value of foreign currencies against the U.S. dollar.
• Noncompliance with data privacy or security laws or any security breach.
• Shortages of raw materials, disruptions in the business of contract manufacturers, and significant price increases of key raw materials.
• Continued compliance with debt covenants in the credit facility.
• Litigation, tax, and legal compliance risk and costs.
• Information technology system failures, data security breaches, and cybersecurity attacks.
• Acquisition, divestiture, and investment-related risks.

Future Outlook

The company believes its current cash balances, future cash provided by operations, and amounts available under its line of credit will be sufficient to cover its operating and capital needs in the ordinary course of business for the foreseeable future. The company is actively assessing potential acquisition opportunities and investments in complementary ventures.

Management Comments

• Management believes that presentation of certain non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of our operations.
• Management believes these measures reflect an additional way of viewing aspects of our business that, when viewed with our U.S. GAAP results, provide a more complete understanding of factors and trends affecting our business.
• Management uses constant currency net sales, local currency net sales, and other currency-related financial information terms to discuss our financial results in a way we believe is helpful in understanding the impact of fluctuations in foreign-currency exchange rates and facilitating period-to-period comparisons of results of operations and providing investors an additional perspective on trends and underlying business results.

Industry Context

The direct selling industry is facing challenges with changing consumer preferences and increased competition. USANA's results reflect these broader trends, with a decline in active customers and sales. The company's performance is also impacted by global economic conditions and currency fluctuations, which are affecting many multinational companies.

Comparison to Industry Standards

• USANA's performance is below the industry average for growth in the direct selling sector, with many competitors showing more resilience in customer acquisition and retention.
• Companies like Herbalife and Nu Skin, which also operate in the nutritional and personal care space, have shown varying degrees of success in different regions, highlighting the competitive landscape.
• USANA's reliance on the direct selling model is a common thread with other companies in the sector, but its ability to adapt to changing market conditions is lagging behind some of its peers.
• The company's gross profit margin of 81.1% is relatively high compared to some other direct selling companies, but its operating expenses are also significant, impacting overall profitability.
• USANA's performance in China, a key market for many direct selling companies, is showing signs of weakness, which is a concern given the importance of this region for growth.

Legal Proceedings

• The company is involved in various lawsuits, claims, and other legal matters from time to time that arise in the ordinary course of conducting business.

Stakeholder Impact

• Shareholders will be negatively impacted by the decrease in earnings and diluted EPS.
• Associates may be impacted by changes in sales and incentives.
• Customers may be impacted by changes in product availability and pricing.
• Employees may be impacted by changes in the company's financial performance.

Next Steps

• The company will continue its efforts to ensure that the control deficiencies contributing to the material weaknesses are remediated.
• The company will continue to review and update IT policies, analyze current processes and control documentation, and establish the appropriate level of responsibility and ownership of ITGCs.
• The company expects that the remediation of these material weaknesses will be completed prior to the end of fiscal year 2024.

Key Dates

Keywords

direct selling, nutritional products, personal care, skincare, Asia Pacific, Americas and Europe, China, sales, earnings, active customers, currency exchange rates, financial results